Since 19th April, Merck has been hitting the upper circuit and today, it hit a new high at Rs.2014, up 15%. The buzz on the counter for the past couple of days has been keeping the stock alive.

The buzz is on news that P&G will be buying a majority stake in Merck for Rs.1290 crore, as part of a global transaction to acquire Merck KGaA’s international consumer health business for $4.2 billion.

Merck’s consumer health business in India is one of the largest in supplying vitamins, minerals and supplements, with products such as Neurobion, Polybion, Femibion and Evion.